LAVAL, QC and CAMBRIDGE, England, Aug. 16, 2023 /PRNewswire/ - Liminal BioSciences Inc. (NASDAQ: LMNL) ("Liminal BioSciences" or the "Company"), announced today that the Ontario Superior Court of ...
LAVAL, QC and CAMBRIDGE, England, Aug. 16, 2023 /PRNewswire/ -- Liminal BioSciences Inc. (NASDAQ: LMNL) ("Liminal BioSciences" or the "Company"), announced today that the Ontario Superior Court of ...
LAVAL, QC and CAMBRIDGE, England, Sept. 19, 2023 /PRNewswire/ - Liminal BioSciences Inc. (NASDAQ: LMNL) ("Liminal BioSciences" or the "Company"), is pleased to announce that it received the final ...
(MENAFN- PR Newswire) LAVAL, QC and CAMBRIDGE, England, Aug. 16, 2023 /PRNewswire/ -- Liminal BioSciences Inc. (NASDAQ: lmnl ) ("Liminal BioSciences" or the "Company"), announced today that the ...
(MENAFN- PR Newswire) LAVAL, QC and CAMBRIDGE, England, Aug. 16, 2023 /PRNewswire/ - Liminal BioSciences Inc. (NASDAQ: lmnl ) ("Liminal BioSciences" or the "Company"), announced today that the Ontario ...
Liminal BioSciences is designing proprietary novel small molecule therapeutic candidates with the intent of developing best/first in class therapeutics for the treatment of metabolic, inflammatory and ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈